These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38315466)

  • 1. Effect of Testosterone on Progression From Prediabetes to Diabetes in Men With Hypogonadism: A Substudy of the TRAVERSE Randomized Clinical Trial.
    Bhasin S; Lincoff AM; Nissen SE; Wannemuehler K; McDonnell ME; Peters AL; Khan N; Snabes MC; Li X; Li G; Buhr K; Pencina KM; Travison TG
    JAMA Intern Med; 2024 Apr; 184(4):353-362. PubMed ID: 38315466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial.
    Pencina KM; Travison TG; Artz AS; Lincoff AM; Nissen SE; Flevaris P; Chan A; Li X; Diegel SA; Wannemuehler K; Bhasin S
    JAMA Netw Open; 2023 Oct; 6(10):e2340030. PubMed ID: 37889486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial.
    Bhasin S; Travison TG; Pencina KM; O'Leary M; Cunningham GR; Lincoff AM; Nissen SE; Lucia MS; Preston MA; Khera M; Khan N; Snabes MC; Li X; Tangen CM; Buhr KA; Thompson IM
    JAMA Netw Open; 2023 Dec; 6(12):e2348692. PubMed ID: 38150256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism.
    Pencina KM; Travison TG; Cunningham GR; Lincoff AM; Nissen SE; Khera M; Miller MG; Flevaris P; Li X; Wannemuehler K; Bhasin S
    J Clin Endocrinol Metab; 2024 Jan; 109(2):569-580. PubMed ID: 37589949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial.
    Spence JD; Viscoli CM; Inzucchi SE; Dearborn-Tomazos J; Ford GA; Gorman M; Furie KL; Lovejoy AM; Young LH; Kernan WN;
    JAMA Neurol; 2019 May; 76(5):526-535. PubMed ID: 30734043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
    JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study.
    Yassin A; Haider A; Haider KS; Caliber M; Doros G; Saad F; Garvey WT
    Diabetes Care; 2019 Jun; 42(6):1104-1111. PubMed ID: 30862651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressive Syndromes in Men With Hypogonadism in the TRAVERSE Trial: Response to Testosterone-Replacement Therapy.
    Bhasin S; Seidman S; Travison TG; Pencina KM; Lincoff AM; Nissen SE; Miller MG; Flevaris P; Li X; Wannemuehler KA; Pope HG
    J Clin Endocrinol Metab; 2024 Jun; 109(7):1814-1826. PubMed ID: 38205962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.
    Wittert G; Bracken K; Robledo KP; Grossmann M; Yeap BB; Handelsman DJ; Stuckey B; Conway A; Inder W; McLachlan R; Allan C; Jesudason D; Fui MNT; Hague W; Jenkins A; Daniel M; Gebski V; Keech A
    Lancet Diabetes Endocrinol; 2021 Jan; 9(1):32-45. PubMed ID: 33338415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus.
    Gopal RA; Bothra N; Acharya SV; Ganesh HK; Bandgar TR; Menon PS; Shah NS
    Endocr Pract; 2010; 16(4):570-6. PubMed ID: 20150021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Safety of Testosterone-Replacement Therapy.
    Lincoff AM; Bhasin S; Flevaris P; Mitchell LM; Basaria S; Boden WE; Cunningham GR; Granger CB; Khera M; Thompson IM; Wang Q; Wolski K; Davey D; Kalahasti V; Khan N; Miller MG; Snabes MC; Chan A; Dubcenco E; Li X; Yi T; Huang B; Pencina KM; Travison TG; Nissen SE;
    N Engl J Med; 2023 Jul; 389(2):107-117. PubMed ID: 37326322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus.
    Shigehara K; Konaka H; Kato Y; Iijima M; Nakashima K; Kawaguchi S; Nohara T; Izumi K; Namiki M; Mizokami A
    Int J Impot Res; 2019 Jan; 31(1):25-30. PubMed ID: 30135606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS).
    Bhattacharya RK; Khera M; Blick G; Kushner H; Miner MM
    Clin Interv Aging; 2012; 7():321-30. PubMed ID: 22956867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes.
    Groti K; Žuran I; Antonič B; Foršnarič L; Pfeifer M
    Aging Male; 2018 Sep; 21(3):158-169. PubMed ID: 29708829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone replacement therapy of opioid-induced male hypogonadism improved body composition but not pain perception: a double-blind, randomized, and placebo-controlled trial.
    Glintborg D; Vaegter HB; Christensen LL; Bendix E; Graven-Nielsen T; Andersen PG; Andersen M
    Eur J Endocrinol; 2020 Jun; 182(6):539-548. PubMed ID: 32213659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
    Giagulli VA; Carbone MD; Ramunni MI; Licchelli B; De Pergola G; Sabbà C; Guastamacchia E; Triggiani V
    Andrology; 2015 Nov; 3(6):1094-103. PubMed ID: 26447645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.
    Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
    Andrology; 2017 Sep; 5(5):905-913. PubMed ID: 28771964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate Risk and Monitoring During Testosterone Replacement Therapy.
    Bhasin S; Thompson IM
    J Clin Endocrinol Metab; 2024 Jul; 109(8):1975-1983. PubMed ID: 38753865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic benefits with adherence to testosterone therapy in men with hypogonadism and type 2 diabetes mellitus.
    Jenkins CR; Rittel A; Sturdivant RX; Wan J; Clerc PG; Manning E; Jenkins LM; Wardian JL; Graybill SD
    Andrology; 2021 Jul; 9(4):1076-1085. PubMed ID: 33606360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.